Verdify is a technology company.
Verdify has raised $1.0M across 1 funding round.
Verdify has raised $1.0M in total across 1 funding round.
Verdify is a Dutch foodtech company specializing in AI-driven personalized nutrition software that enables better food choices for personal health and planetary sustainability.[1][2][6] It powers platforms like NooryMed (for healthcare providers managing patient nutrition remotely) and Noory (a consumer app for meal planning), while integrating "swap" features on recipe websites and food blogs to suggest healthier, sustainable alternatives like plant-based options.[1][2][7] Serving healthcare professionals, patients (e.g., those with breast cancer or obesity), consumers, supermarkets, and food retailers, Verdify addresses diet-related health risks such as cardiovascular disease, cancer, diabetes, and IBS by personalizing recipes based on medical data, dietary needs, and environmental impact.[2][3] The company has shown strong growth momentum, raising €2.4 million in January 2024 to expand NooryMed globally for breast cancer and obesity treatment, integrate with 100 more recipe sites, and partner with entities like Roche, EIT Food, and supermarkets including Albert Heijn.[2][6]
Verdify emerged from CEO Jochem Bossenbroek's frustration with healthcare's focus on treating symptoms rather than preventing them through nutrition, inspired by his biotechnology and life sciences background and research linking diet to health outcomes.[3] Co-founded by Jochem Bossenbroek and Sandrin Bergheanu (now Co-Founder & Advisor) around 2017-2020, the company launched its AI platform in November 2019, initially linking supermarket recipe databases to consumers with special needs like low-salt, low-carb diets, pregnancy, or gut issues such as IBS and Crohn's.[2][3][5] Early traction came from partnering with Albert Heijn, where users could personalize recipes and add ingredients to shopping lists, prompting interest from other retailers and a shift to B2B licensing of "swap" technology on recipe sites.[3] Pivotal moments include recent funding (€2.4M in 2024, €670k from EIT Food), NooryMed testing with Roche for breast cancer patients, and a leadership transition announced recently, with Martijn Everts now as CEO.[2][6]
Verdify rides the wave of personalized nutrition and AI in foodtech, capitalizing on established links between diet, chronic diseases (e.g., diabetes, cancer), and sustainability amid rising consumer demand for healthy, eco-friendly eating.[2][3][6] Timing is ideal post-2020s health crises and climate awareness, with market forces like obesity epidemics, preventive healthcare shifts, and retailer digitization favoring its B2B model—supermarkets seek engagement tools, while pharma like Roche integrates nutrition into treatments.[2][6] It influences the ecosystem by licensing tech to retailers (e.g., Albert Heijn), blogs reaching millions, and accelerators like EIT Food, accelerating adoption of AI for prevention over cure and nudging planetary health via sustainable swaps.[3][6]
Verdify is poised to scale NooryMed globally for obesity and cancer care, embed swaps across 100+ recipe sites, and deepen retail/pharma ties amid AI nutrition booms.[2][6] Trends like hyper-personalized health tech, regulatory pushes for sustainability, and AI automation will propel it, potentially evolving from startup to key player in preventive foodtech ecosystems. As a pioneer making nutrition actionable, Verdify exemplifies how software can bridge personal well-being and planetary health in an era of complex food choices.[1][6]
Verdify has raised $1.0M in total across 1 funding round.
Verdify's investors include Brightlands Venture Partners.
Verdify has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2021 | $1.0M Seed | Brightlands Venture Partners |